SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients

Sofie Leisby Antonsen, Annika Loft, Rune Vincents Fisker, Anne Lerberg Nielsen, Erik Søgaard Andersen, Estrid Høgdall, Ann Tabor, Kirsten Væver Jochumsen, Carsten L Fagö-Olsen, Jon Asmussen, Anne Kiil Berthelsen, Ib Jarle Christensen, Claus Høgdall

40 Citations (Scopus)

Abstract

To evaluate SUVmax in the assessment of endometrial cancer preoperatively with particular focus on myometrial invasion (MI), cervical invasion (CI), FIGO stage, risk-stratification and lymph node metastases (LNM).
Original languageEnglish
JournalGynecologic Oncology
Volume129
Issue number2
Pages (from-to)298-303
Number of pages6
ISSN0090-8258
DOIs
Publication statusPublished - May 2013

Keywords

  • Adenocarcinoma
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinosarcoma
  • Endometrial Neoplasms
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Hysterectomy
  • Linear Models
  • Lymph Node Excision
  • Middle Aged
  • Multimodal Imaging
  • Ovariectomy
  • Pelvis
  • Positron-Emission Tomography
  • Preoperative Care
  • Prognosis
  • Prospective Studies
  • ROC Curve
  • Radiopharmaceuticals
  • Risk Assessment
  • Salpingectomy
  • Tomography, X-Ray Computed

Fingerprint

Dive into the research topics of 'SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients'. Together they form a unique fingerprint.

Cite this